Pharma Mar SA
María Julián Esquivias has a diverse work experience in the field of biotechnology and pharmaceuticals. María started their career as an Investigator at the Instituto de Patología Vegetal in 1993 and later moved to the Centro Nacional de Biotecnología CNB-CSIC, where they worked as an Investigator from 1996 to 1998. In 1999, they joined Schering A.G. as a Product Manager until 2002. María then joined PharmaMar, where they held various roles, including International Product Manager from 2002 to 2009, and later International Marketing Associate Director from 2010 onwards. In 2021, María Julián Esquivias started working as a Docente Master Biotecnología de la Salud at CESIF.
María Julián Esquivias completed their education in the field of science at Universidad Autónoma de Madrid. María obtained a Licenciada en Ciencias Químicas degree in 1992, followed by a Doctora en Biología Molecular degree between 1996 and 1998.
This person is not in the org chart
This person is not in any offices
Pharma Mar SA
Pharma Mar SA is a Spain-based company engaged in the bio therapeutic drugs manufacture. The Company focuses on research, development and marketing of bio-active principles, primarily from marine origin, for application in human diseases treatment, including antitumour, antiviral and immunomodulation, as well as tropical diseases areas. It manufactures and sells Yondelis, a synthetically modified antitumor agent, which is derived from sea squirts and is implemented in the treatment of soft tissue sarcomas and relapsed ovarian cancer. Furthermore, the Company's products pipeline comprises drug candidates and agents for cancer treatment, such as Aplidin, PM01183 and PM060184. The Company operates through subsidiaries in Italy, Germany, France, and the United States, among others.